Summary

Meet our Team and registered for our Lunch and Learn Roundtable on Wednesday April 28, 2021 from 1:10 pm - 1:50 pm (EST) !

Our team

 Julien Depollier 
 Director Strategic Partnerships 
About Julien Depollier
Director Strategic Partnerships
Aucune information.
 Tom KRESGE 
 VP Sales US 
About Tom KRESGE
VP Sales US
Aucune information.
 Ashlee Sun 
 Field Application Specialist - AMERICAS 
About Ashlee Sun
Field Application Specialist - AMERICAS
Aucune information.
 Cassie-Marie Peigné 
 Scientific Support Specialist 
About Cassie-Marie Peigné
Scientific Support Specialist
Aucune information.

Lunch & Learn Roundtable – April 28: 1:10 pm – 1:50 pm EST

How to improve viral titers by optimizing your upstream process?

The current challenges in Gene therapy are increasing viral titer yields, and optimizing the industrial production process of AAVs that are becoming the leading viral vector used to develop Gene therapy. Optimizing key parameters of the upstream process, such as the critical transfection step, can really accelerate the time to market of gene therapies, and in sufficient amount to address diseases with larger patient population or that require bigger doses per patient. Come to discuss with the worldwide leader in transfection Polyplus-transfection during this exciting roundtable.

Roundtable hosted by Julien DEPOLLIER, Director Strategic Partnerships at Polyplus-transfection®.

 

Our solutions for both protein and virus production

FectoVIR®-AAV: for Recombinant AAV virus production in suspension cells.

PEIpro® product range for a scalable viral vector production for Gene & Cell therapy.

FectoPRO® Transfection kit is specifically designed for enhanced Transient Gene Expression (TGE) in suspension CHO and HEK-293 cells in various serum-free media, using low DNA amount (< 1 µg/ml of cell culture).

General information

Registration link for virtual event: click here
Give your feedback!